Recruiting

Self-Monitoring Platform

Sponsor:

University of Michigan Rogel Cancer Center

Code:

NCT07291414

Conditions

Breast Carcinoma

Colorectal Carcinoma

Lung Carcinoma

Malignant Solid Neoplasm

Prostate Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Educational Intervention

Electronic Health Record Review

Follow-Up

Internet-Based Intervention

Interview

Study Details

Brief summary:

This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become "vigilant partners" in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.

Conditions

Breast Carcinoma

Colorectal Carcinoma

Lung Carcinoma

Malignant Solid Neoplasm

Prostate Carcinoma

Study ID

NCT07291414

Start date

Jan 9, 2026

Status verified date

Jan, 2026

Completion date

Jan 1, 2028

Anticipated

Primary completion date

Jan 1, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participants are adult patients (aged 18 years or older)
  • Diagnosed with lung, colorectal, breast, or prostate cancer
  • Are currently receiving active cancer treatments
  • Are self-managing one or more prescribed cancer medications
  • Participants must have access to technology devices (smartphone, tablet, computer) to track their experiences or concerns about medication safety events, or their family members can help them access technology devices to track the events or concerns
  • Speaks and reads English or has a support person (family member or friend) who can assist

Exclusion Criteria:

  • Can't access technology or do not use technology
  • Do not have access to the internet
  • Do not speak or read English
  • Not permitted to participate by their health care providers

Study Design

Enrollment

80 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Health services research (self-monitoring platform)

Patients use the self-monitoring platform to track medication-related safety events and issues at home for 6 months. Patients may receive relevant educational materials and resources via the platform or by email and/or receive follow-up contact from a nurse practitioner as needed over the 6 months. Patients are encouraged to continue using the platform for an additional 6 months after the study period, as desired.

Interventions

Educational Intervention

Receive educational materials and resources

Electronic Health Record Review

Ancillary studies

Follow-Up

Receive follow-up contact

Internet-Based Intervention

Use self-monitoring platform

Interview

Ancillary studies

Survey Administration

Ancillary studies

Primary outcome measure

  • Self-reported system usability [ Time Frame: Up to 6 months ]
  • Perceived usefulness [ Time Frame: Up to 6 months ]
  • Ease of use [ Time Frame: Up to 6 months ]
  • Attitudes toward use [ Time Frame: Up to 6 months ]
  • Intention to use and continuous use of the system over time [ Time Frame: Up to 12 months ]
  • Self-reported patient engagement [ Time Frame: Up to 6 months ]
  • System usage over time [ Time Frame: Up to 12 months ]
  • Patient activation levels [ Time Frame: Up to 6 months ]
  • Medication self-management ability [ Time Frame: Up to 6 months ]
  • Symptom distress [ Time Frame: Up to 6 months ]
  • Health related quality of life [ Time Frame: Up to 6 months ]
  • Number of emergency room visits [ Time Frame: Up to 12 months ]
  • Number of hospitalizations [ Time Frame: Up to 12 months ]
  • User experiences with the system [ Time Frame: Up to 6 months ]

Central Contacts and Locations

Central contacts

Locations

University of Michigan Comprehensive Cancer Center

Recruiting

Ann Arbor, Michigan, United States, 48109

Contacts

Principal Investigator:

Yun Jiang

More Information

Sponsor

University of Michigan Rogel Cancer Center

Last update posted

Jan 21, 2026

Last verified

Jan, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Michigan Rogel Cancer Center on 2026-01-21.